| Literature DB >> 23746973 |
Chris Mason1, Julian Mason, Emily J Culme-Seymour, Gregory A Bonfiglio, Brock C Reeve.
Abstract
During Q4 2012 and Q1 2013, the cell therapy industry made strong progress in translation and commercialization. Continued development of the companies included in a dedicated stock market index suggests emergence of this industry as a distinct healthcare sector.Mesh：
Year: 2013 PMID： 23746973 DOI： 10.1016/j.stem.2013.05.017
Source DB: PubMed Journal: Cell Stem Cell ISSN： 1875-9777 Impact factor: 24.633